Article Details

SpringWorks Therapeutics' (NASDAQ:SWTX) Buy Rating Reaffirmed at HC Wainwright

Retrieved on: 2020-01-03 08:22:30

Tags for this article:

Click the tags to see associated articles and topics

SpringWorks Therapeutics' (NASDAQ:SWTX) Buy Rating Reaffirmed at HC Wainwright. View article details on hiswai:

Excerpt

<div>SpringWorks Therapeutics (NASDAQ:SWTX)'s stock had its “buy” rating reissued by research analysts at HC Wainwright in a report released on ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up